Szöke, A, Trandafir, A, Dupont, ME, Méary, A, Schürhoff, F, Leboyer, M. Longitudinal studies of cognition in schizophrenia:
meta-analysis. Br J Psychiatry
2008; 192: 248–57.
Rund, BR. A review of longitudinal studies of cognitive
functions in schizophrenia patients. Schizophr
1998; 24: 425–35.
Woodward, ND, Purdon, SE, Meltzer, HY, Zald, DH. A meta-analysis of neuropsychological change to
clozapine, olanzapine, quetiapine, and risperidone in
schizophrenia. Int J
2005; 8: 457–72.
Goldberg, TE, Goldman, RS, Burdick, KE, Malhotra, AK, Lencz, T, Patel, RC, et al. Cognitive improvement after treatment with
second generation antipsychotic medications in first-episode
schizophrenia: is it a practice effect?
Arch Gen Psychiatry
2007; 64: 1115–22.
Buchanan, RW, Davis, M, Goff, D, Green, MF, Keefe, RS, Leon, AC, et al. A summary of the FDA-NIMH-MATRICS workshop on
clinical trial design for neurocognitive drugs for
schizophrenia. Schizophr Bull